Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-CEACAM5 Antibody-PE (1G568)

🥰Excellent
Catalog No. TMAY-01601P

Anti-CEACAM5 Antibody-PE (1G568) is a PE-conjugated Mouse antibody targeting CEACAM5. Anti-CEACAM5 Antibody-PE (1G568) can be used in FCM.

Anti-CEACAM5 Antibody-PE (1G568)

Anti-CEACAM5 Antibody-PE (1G568)

🥰Excellent
Catalog No. TMAY-01601P
Anti-CEACAM5 Antibody-PE (1G568) is a PE-conjugated Mouse antibody targeting CEACAM5. Anti-CEACAM5 Antibody-PE (1G568) can be used in FCM.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Anti-CEACAM5 Antibody-PE (1G568) is a PE-conjugated Mouse antibody targeting CEACAM5. Anti-CEACAM5 Antibody-PE (1G568) can be used in FCM.
Ig Type
Monoclonal Mouse IgG2a
Clone
1G568
Reactivity
Human
Verified Activity
Flow cytometric analysis of anti-Human CEACAM5 on HT29 cells.
Application
FCM
Recommended Dose
2 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CEACAM5 / CD66e (rh CEACAM5 / CD66e; TMPY-01647; NP_004354.2; Met1-Ala685) and conjugated with PE under optimum conditions, the unreacted PE was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.03%ProClin300
Research BackgroundCEACAM5, also known as CEA or CD66e, belongs to the large CEACAM subfamily of the immunoglobulin superfamily. CEACAM5 is expressed primarily by epithelial cells, and is synthesized as a glycoprotein with an MW of 180 kDa comprising 60% carbohydrate. CEACAM5 contains one Ig-like V-type domain at the N-terminus, followed by six Ig-like C2-type domains and a GPI anchor, and exists as a homodimer. CEACAM5 and CEACAM6 are overexpressed in many cancers and are associated with adhesion and invasion. CEACAM5 can mediate cell-cell adhesion through homotypic and heterotypic interactions. It functions as a homotypic intercellular adhesion molecule and serves as a widely used tumor marker, since it is expressed at higher levels in tumorous tissues than in corresponding normal tissues. CEACAM5 has also been shown to contribute to tumorigenicity by inhibiting cellular differentiation. In addition, CEACAM5 is identified as the host receptor for the Dr family of adhesins of E.Coli, and the binding of E.coli Dr adhesins leads to dissociation of the CEACAM5 homodimer.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
PE
Others Formats
Unconjugated
Antibody Types Available
2
Antigen Details
Immunogen
Recombinant Human CEACAM5 / CD66e protein (TMPY-01647)
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight.
TransportShipping with blue ice.

Sci Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Anti-CEACAM5 Antibody-PE (1G568) | purchase Anti-CEACAM5 Antibody-PE (1G568) | Anti-CEACAM5 Antibody-PE (1G568) cost | order Anti-CEACAM5 Antibody-PE (1G568)